In this study, we found that ZRH as a PPARγ activating medication can regulate inflammatory factors and adipokines, suppress lipid metabolism disorders and inflammation, enhance adipose tissue “brown,” increase AS plaque stability, and improve plasma lipidomic features. Here, PPARG is linked to Disorder of lipid metabolism.